IBD studies

An active post-marketing surveillance study to investigate the Tofacitinib safety to characterize in the clinical practice of patients with moderately to severely active ulcerative colitis, based on data from the United Registries for Clinical Assessment and Research (UR-CARE).

A double-blind, placebo-controlled phase III study of the efficacy and safety of induction and maintenance therapy with RO7790121 in patients with moderately to severely active ulcerative colitis.

A multicentric study that demonstrates the systematic start of biological therapy immediately after a surgical resection compares with the more targeted start of biological therapy in patients with endoscopic injuries six months after surgery.

A study into the combination of FIT diet with biologytherapie in patients with Crohn's disease.

A randomized controlled trial that therapy escalation evaluates in patients with moderate postoperative recurrence of Crohn's Disease.

An interventional study into customized treatment for patients with moderately to severely active Crohn's disease, focused on transmural healing.

A randomized, double-blind, placebo-controlled trial evaluating efficiency and safety of Tulisokibart in patients with moderately to severely active Crohn's disease.

A prospective, randomized treatment selection trial in adults with the Crohn's disease, using epigenetic markers versus standard treatment.

A study on the use of subcutaneous Infliximab after a previous intravenous dose optimization in patients with Crohn's disease or ulcerative colitis.

A study into the natural history, risk factors, and incidence of immune-mediated enterocolitis in patients with inflammatory bowel disease (IBD) that are treated with immune checkpoint inhibitor (ICI) therapy.